Sarepta shares plunge 40% as future of its gene therapy appears at risk
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, ...
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, ...
BRCA gene test questioned after unnecessary surgeries - CBS News
Sopa Images | Lightrocket | Getty ImagesBluebird Bio will sell itself to private equity firms Carlyle and SK Capital for ...
PHILADELPHIA (CBS) -- There's new hope for people with sickle cell disease, which affects mainly African Americans. It's gene therapy ...
London — One of the youngest children in the world to receive a new type of gene therapy to treat ...
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. ...
FDA approves first gene therapy for sickle cell disease - CBS News
Expert joins CBS New York to discuss new sickle cell treatment Expert joins CBS New York to discuss new sickle ...
© 2024 LSD News title="Jegtheme">Jegtheme.